Dupilumab's Successful Journey in Pityriasis Lichenoides Chronica Followed by the Intriguing Reemergence of Vitiligo After Monobenzone Depigmentation: A Case Report
This case highlights dupilumab's potential as an effective treatment for PLC and its possible role in promoting skin repigmentation in a patient with prior vitiligo. These findings suggest a potential link between type 2 inflammation and PLC pathogenesis, warranting further investigation. Dupilumab may represent a promising therapeutic alternative for refractory PLC.
Authors
- Mohammed Aljughayman (ORCID: https://orcid.org/0000-0001-8186-473X)
- Nouf Almuhanna (ORCID: https://orcid.org/0000-0002-4828-4562)
- Khalid Nabil Nagshabandi (ORCID: https://orcid.org/0009-0008-6577-6463)
- Asem Shadid (ORCID: https://orcid.org/0000-0002-7422-781X)
- Salman Almalki
Institutions
- King Fahd Medical City (SA)
- King Saud University (SA)
Publication Details
- Journal
- Case Reports in Dermatology
- Published
- 2025-05-15
- DOI
- https://doi.org/10.1159/000545212
- Citations
- 1
- Primary Topic
- Cutaneous lymphoproliferative disorders research
- Type
- article
- Field-Weighted Citation Impact
- 2.00